Randy T. McConnell - Concepedia

Author

Randy T. McConnell

Research Triangle Park Foundation

Also Known As

R T McConnell, R. McConnell, R. T. McConnell, R.T. McConnell, Randy McConnell, Randy T. McConnell

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Duke University GlaxoSmithKline (Netherlands)Burroughs Wellcome Fund

About

Randy T. McConnell is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.9K
2	Biochemistry	13	14	1.6K
3	Natural Sciences	5	5	428
4	Cell Biology	5	5	623
5	Health Sciences	2	2	521

Randy T. McConnell

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. Steve P. Watson, Randy T. McConnell, E G Lapetina Journal of Biological Chemistry ThrombosisHuman PlateletsThrombin-induced FormationHematologyInositol Phosphates	1984	315
Characterization of an Akt Kinase Inhibitor with Potent Pharmacodynamic and Antitumor Activity Nelson Rhodes, Dirk A. Heerding, Derek R. Duckett, Cancer Research Tumor XenograftsAntitumor ActivityChemoprevention StrategyApoptosisImmunology	2008	296
Regulation of arachidonate metabolism via lipoxygenase and cyclo-oxygenase by 12-HPETE, the product of human platelet lipoxygenase Marvín I. Siegel, Randy T. McConnell, Sanders L. Abrahams, Biochemical and Biophysical Research Communications OxysterolBiochemistryMedicineLipid PeroxidationPhysiology	1979	206
Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway. Marvín I. Siegel, Randy T. McConnell, Pedro Cuatrecasas Proceedings of the National Academy of Sciences Lipid PeroxidationPharmacotherapyEc 1.14.99.1Redox BiologyOxidative Stress	1979	204
Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase Dirk A. Heerding, Nelson Rhodes, Jack D. Leber, Journal of Medicinal Chemistry Cell DeathAkt KinaseMolecular PharmacologyMedicinal ChemistryReceptor Tyrosine Kinase	2008	154
<i>In vitro</i> biological activity of a novel small-molecule inhibitor of polo-like kinase 1 Timothy J. Lansing, Randy T. McConnell, Derek R. Duckett, Molecular Cancer Therapeutics	2007	139
Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. Margrith W. Verghese, Randy T. McConnell, A B Strickland, Journal of Pharmacology and Experimental Therapeutics	1995	135
Collagen stimulates [3H]inositol trisphosphate formation in indomethacin-treated human platelets Steve P. Watson, Bryan R. Reep, Randy T. McConnell, Biochemical Journal InflammationThrombosisThrombopoiesisHuman PlateletsSignal Transduction	1985	124
Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Margrith W. Verghese, Randy T. McConnell, James M. Lenhard, Molecular Pharmacology	1995	118
Arachidonate metabolism via lipoxygenase and 12L-hydroperoxy-5,8,10,14-icosatetraenoic acid peroxidase sensitive to anti-inflammatory drugs. Marvín I. Siegel, Randy T. McConnell, N A Porter, Proceedings of the National Academy of Sciences Anti-inflammatory DrugsLipid PeroxidationPlatelet CytosolRedox BiologyOxidative Stress	1980	117

Page 1